Oncology PracticeASCO: Extend adjuvant endocrine therapy to 10 yearsMay 27, 2014Breast CancerGynecologic Cancer
Oncology PracticeASCO 2014: Dr. Hope S. Rugo gives her top picks in breast cancer researchMay 27, 2014Breast Cancer
The Journal of Community and Supportive OncologyTaking the data and findings into the real-world settingMay 27, 2014Breast CancerLeukemia, Myelodysplasia, TransplantationPatient & Survivor Care
Oncology PracticeBreast cancer fear contributes to prophylactic mastectomy rateMay 21, 2014Breast Cancer
Oncology PracticeObesity increased breast cancer mortality only in premenopausal womenMay 15, 2014Breast CancerPreventive Care
Oncology PracticeASCO guidelines address targeted treatments of HER2-positive breast cancer May 9, 2014Breast Cancer
Oncology PracticeFirst SEER analysis including HER2 subtype is reportedMay 9, 2014Preventive CareBreast Cancer
Oncology PracticeLower-dose chest radiation in childhood still carries high risk for breast cancerApril 29, 2014PediatricsBreast Cancer
Oncology PracticeTopical lidocaine reduces menopausal dyspareuniaApril 25, 2014Breast CancerGynecologic CancerPatient & Survivor Care
Oncology PracticePalbociclib shows promise in advanced ER-positive breast cancer patientsApril 16, 2014Breast Cancer
Oncology PracticeFirst ASCO survivor care guidelines tackle fatigue, anxiety/depression, neuropathyApril 14, 2014Breast CancerPatient & Survivor CareGynecologic Cancer
The Journal of Community and Supportive OncologyPertuzumab in neoadjuvant treatment of HER2-positive early breast cancerMarch 26, 2014Breast Cancer
Oncology PracticePostmastectomy radiotherapy improves survival with one to three positive nodesMarch 25, 2014Breast Cancer